Material
N atural killer cells are innate lymphoid cells that are distinct from adaptive T and B lymphocytes in developmental and functional properties (1) (2) (3) . Although all lineages develop from the common lymphocyte progenitor, NK cell development proceeds through a distinct set of intermediates in the bone marrow (BM), where they undergo an education process and become functionally competent (4) . NK cells further mature in the periphery, with changes in function marked by different cell-surface proteins including CD11b, CD27, CD43, and CD62L (5) . In the most common murine NK cell differentiation classification, increased maturation correlates with decreasing proliferative capacity and increasing functional capacity as defined by a four-stage sequential model in which NK cells mature from CD27 (6, 7) . Mouse NK cell functional capacity may be measured by the release of immunomodulatory cytokines, such as IFN-g, through stimulation of surface activating receptors such as NK1.1, Ly49H, and NKG2D, as well as cytokine signals such as those provided by IL-12, IL-15, and IL-18 (8) (9) (10) . In addition, NK cell function is defined by the directed release of cytotoxic granules containing granzyme B and perforin onto the surface of target cells, thereby inducing an apoptotic-like cell death (11, 12) . Thus, effective NK cell functional responses depend on appropriate maturation events in the periphery.
Despite the known functional differences between immature and mature NK cells, our understanding of the molecular networks governing NK cell maturation remains limited (13, 14) . Early NK cell development is controlled by factors such as Nfil3 (15), Id2 (16), Hnf1a (Tcf-1) (17) , and Tox (18) . Of these, Nfil3 has been shown to be the most specific for the NK lineage, but is critical only in early NK cell development, and its requirement can be superseded by activation receptor-driven expansion (19) . In later differentiation, numerous factors are required, such as Gata3 (20) , Prdm1 (Blimp1) (21) , Ets1 (22) , T-bet (23) , and Eomes (24) . Additional molecular mechanisms regulating NK cell maturation remain to be elucidated.
MicroRNAs (miRNAs) are small, 18-22 nt noncoding RNAs that regulate protein production by binding to semicomplementary sites in the 39 untranslated region (UTR) of target mRNAs (25) . In lymphocytes, a number of miRNAs have been shown to control the development and regulation of immune responses (26, 27) , and several miRNAs regulate the development and biology of NK cells (28, 29) . One highly conserved miRNA family, miR-15/16 (30) , is comprised of mature miR-15a, miR-15b, and miR-16 in lymphocytes and shares a high degree of sequence homology and predicted mRNA targets. These miRNAs are highly expressed in NK cells (31, 32) and have been found to inhibit B cell proliferation (33) and promote cellular apoptosis (34) . miR-15/16 members are transcribed from two distinct genomic loci: the miR-15a/16-1 cluster located intronic to the DLEU2 gene and the miR-15b/16-2 cluster found intronic to the SMC4 gene. The miR-15/16 miRNA family contribution to the regulation of NK cell biology is unknown.
Myb (also known as c-Myb) is the prototypical transcription factor of the Myb family (35) , which includes Myb, Mybl1 (a-Myb), and Mybl2 (b-Myb), and operates primarily as a transcriptional activator through binding of the sequence t/cAACt/gG (36) . Myb is required for normal hematopoiesis, and the Myb global genetic knockout is embryonic lethal in mice due to hematopoietic failure (37) . Myb is predicted to be regulated by a number of miRNAs, including miR-15/16 in human cell lines (38) . Another miRNA highly expressed in NK cells, miR-150, was shown to target Myb in B cells (39) , with deletion of miR-150 leading to enhanced proliferation and defective B cell differentiation. miR-150 has also been shown to regulate NK and NK-T cell development (40) , with its global deletion leading to defects in the development and maturation of NK cells, potentially through its role in regulating Myb. In this report, the impact of Myb on NK cells was examined in global Myb +/2 mice, which were shown to have increased NK cell percentages, correlating with expanded NK cell percentages in miR-150-overexpressing transgenic mice (40) . Thus, Myb is a transcription factor important for hematopoietic development, and the regulation of its expression in NK cells remains a relevant question in lymphocyte biology.
In this study, we hypothesized that miR-15/16 family miRNAs contributetotheregulation of NKcelldevelopmentand/or function. To address this, we generated a previously unreported mouse model that specifically deletes the miR-15a-16-1 loci in NK cells using Cre/Lox technology, thereby resulting in reduced expression of miR-15/16 miRNAs. This mouse manifested defective NK cell maturation with a block in terminal differentiation into stage IV CD27 
Materials and Methods

Mice
The 15a/16-1 floxed knockout (FKO) mice were generated by crossing either Tg(Ncr1-iCre)265Sxl mice (41) or B6.Cg-Tg(CD2-cre)4Kio/J (42) with mice containing a LoxP-flanked miR-15a/16-1 allele (33) as well as a Rosa26-STOP-eYFP allele, obtained from The Jackson Laboratory as B6.129 3 1-Gt(ROSA)26Sor tm1(EYFP)Cos /J (43) . In some experiments, Nkp46 iCre knockin mice (44) were used instead of Tg(Ncr1-iCre)265Sxl and had an equivalent phenotype. CD45.1 congenic mice were obtained from the National Cancer Institute. RAG 2/2 g c 2/2 mice were obtained from Taconic Farms. All mice were either generated on a C57BL/6 background or backcrossed at least 10 times to B6. All mice have been bred and maintained in specific pathogen-free housing, and all experiments were conducted in accordance with the guidelines of and the approval of the Washington University Animal Studies Committee. Agematched mice were used between 8 and 12 wk of age for all experiments.
Cell lines
The 293T cells were maintained in complete DMEM (DMEM with 10% FBS, 10 mmol HEPES, 50 mmol 2-ME, 100 U/ml penicillin and streptomycin, 1 mmol sodium pyruvate, and 13 nonessential amino acids). KY-1 and KY-2 cell lines were maintained in complete RPMI (RPMI 1640 with the above additives) + 200 IU/ml recombinant human IL-2. Cell isolation and sorting. Mouse tissues were isolated as previously described (45, 46) .
Immunoblots
A total of 1 3 10 6 sorted mouse YFP + CD27 +/2 or human CD56 bright/dim NK cells were lysed in RIPA buffer, run on an 8-10% SDS-PAGE Gel (BioRad), and transferred to Immobilon-P (Millipore) membrane. Immunostaining was performed with Myb at 1:200, b-actin at 1:500 overnight at 4˚C. Densitometric quantification was performed using ImageJ (National Institutes of Health).
IFN-g assays
IFN-g assays were performed as previously described (47) .
Real-time quantitative RT-PCR
RNA from sorted cells was isolated using TRIzol (Invitrogen) according to the manufacturer's instructions. cDNA was generated using the High-Capacity cDNA Reverse Transcription Kit (Life Technologies). Myb expression was detected in sorted NK cells using IDT PrimeTime Assay Hs.PT.56a.1442895 and normalized to 18S rRNA. miR-15a/miR-15b/miR-16/sno-135 were detected using TaqMan primer/probes and normalized to sno-135 by the DDC t method. Myb-targeted genes were validated using PrimerBank primers, the sequences of which are available upon request. All real-time quantitative RT-PCR was performed on an ABI StepOne machine (Applied Biosystems).
Luciferase assays
Mature miRNAs and luciferase reporter plasmids were overexpressed as previously described (32) . Briefly, the Myb 39 UTR was cloned from Myb cDNA into the psiCheck2 (Promega, Madison, WI) vector using PCR. The two predicted miR-15/16 binding sites were disrupted (cgctgcta to cgGACGta, and tgctgct to tgGACct) using the QuikChange II site-directed mutagenesis Kit (Agilent Technologies, Santa Clara, CA) following the manufacturer's instructions. Luciferase assays were performed using the Dual-Glo Luciferase Assay (Promega) as described previously (46, 47) . Renilla luciferase (experimental) was normalized to Firefly luciferase (transfection control) followed by comparison of Renilla/Firefly ratios of the same psiCheck2 sensor plasmid cotransfected with an empty GFP-only control vector. For assays with the mutated Myb 39 UTR, the ratio of miR15/16 overexpression (OE) plus empty psiCheck2 plasmid (control) was set equal to 1, and the luciferase activity of miR15/16 OE plus psiCheck2-Myb or Myb-mutant was normalized relative to the control.
Flow cytometry
All flow cytometry was performed on a Gallios Flow Cytometer (Beckman Coulter) and analyzed in FlowJo (Tree Star).
Cell isolation and sorting
Briefly, single-cell suspensions were generated from spleen (mechanical disruption through a 70-mmol filter or glass tissue homogenizer), BM (flushing tibia with K10), liver (glass tissue homogenization followed by Percoll gradient isolation), or blood (cardiac puncture). RBC lysis was performed using ACK buffer, and viable cell numbers were determined by Nexcelom cellometer (Nexcelom) (propidium iodide exclusion) or hematocytometer (trypan blue exclusion). Isolation of highly purified NK cells ($98% pure) was performed by flow cytometric sorting on a BD Aria II (BD Biosciences) by gating on forward light scatter/side scatter, CD45 + CD3 
Normal human donors
Anonymous human NK cells were obtained from platelet donors undergoing apheresis at the Barnes Jewish Hospital apheresis center. Leukocyte reduction filters are obtained immediately after apheresis, flushed, and fresh PBMC and NK cells were isolated as described (47) . 
Lentiviral transduction and adoptive transfer
CD3
2 cells were sorted and resuspended in TRIzol (Invitrogen). RNA was processed as for the splenic NK cells. Data for comparisons to primary NK cells were accessed from GSE13229 (6) and filtered for probe sets with a mean expression greater than three when analyzed using Partek with normalization as above. Myb was additionally excluded from this analysis.
Statistical analysis
Statistical comparisons were made using the Student t test or ANOVA as appropriate, with a p value , 0.05 considered significant.
Results
miR-15/16 are highly expressed in NK cells and predicted to target genes involved in cell proliferation and differentiation
The miR-15/16 family is highly conserved and highly expressed in both mouse and human NK cells. As a family, mature miR-15/16 miRNA sequences represent 10% of the overall miRNA sequence in mouse NK cells and are expressed throughout NK cell differentiation (32) (Fig. 1A) . miR-15/16 is bioinformatically predicted (48) to target a number of genes involved in fundamental pathways (Database for Annotation, Visualization and Integrated Discovery) (49), including developmental processes, protein modification, intracellular signaling cascades, cell cycle, cell proliferation and differentiation, cell cycle control, and regulated exocytosis (p value ,3.1E-04; false discovery rate ,0.01). In order to investigate the NK cell-intrinsic molecular regulation by miR-15/16, we generated a model of NK cell-specific miR-15/16 deficiency. This model combined a conditional knockout (LoxP-flanked) mir-15a/16-1 allele (33) with an NK cell-specific Cre recombinase (Ncr1-iCre) ( 
miR-15a/16-1FKO mice have defective NK cell maturation
Mice with NK cell-specific miR-15a/16-1 deletion (15a/16-1FKO) had normal NK cell frequencies in the spleen, BM, liver, and blood. Additionally, in a complementary model of lymphocyte-specific mir-15a/ 16-1 excision (using hCD2-Cre mice) (46), lymphocyte frequencies, NK cell frequencies, and NK receptor repertoires were also normal (Supplemental Fig. 1 ). We hypothesized, due to miR-15/16's predicted targeting of cellular-differentiation pathways, that 15a/16-1FKO NK cells may have developmental defects. We analyzed early NK cell development in the BM and found no differences in early NK cell developmental precursors (Supplemental Fig. 1H, 1I ). However, peripheral NK cell maturation was markedly disrupted in 15a/16-1FKO mice ( Fig. 2A, 2B ), predominantly in the stage III to stage IV transition, when CD27 is downregulated. The expression of CD43, a marker of terminal NK cell maturation, was also reduced in 15a/16-1FKO consistent with a less mature NK cell phenotype (Supplemental Fig. 2A ). In the spleen, total NK cell numbers and percentages were unchanged; however, the number of 15a/16-1FKO NK cells at stage III was increased, whereas stage IV NK cell numbers were reduced, suggesting a block in maturation (Fig. 2C ). This phenotype was consistent in other tissues examined (Fig. 2D, 2E ), and we observed a modest decrease in the absolute number of NK cells in the lung, fitting with their phenotype as stage IV NK cells (Supplemental Fig. 1 ). We also confirmed these phenotypes in the hCD2-Cre model (Supplemental Fig. 1A, 1B) . Moreover, we were unable to detect any changes in the death of stage IV NK cells from 15a/16-1FKO mice immediately ex vivo, suggesting that the change in maturation stages was not due to reduced survival of stage IV NK cells (Supplemental Fig. 2C, 2D ). Collectively, these findings are consistent with miR-15a/16-1FKO NK cells having a block in maturation transition from stage III to stage IV. ) recipient mice (Supplemental Fig. 3D, 3E ). Following transfer, 15a/16-1FKO NK cells expanded with a durable increase in NK cell numbers compared with control YFP + NK cells (Supplemental Fig. 3D, 3E ). Thus, 15a/16-1FKO NK cells exhibit enhanced proliferation after stimulation with IL-15 and increased expansion in vivo under conditions that result in homeostatic proliferation. Thus, enhanced proliferation may contribute to the accumulation of stage III NK cells in 15a/16-1FKO mice, but does not appear to explain the decreased number of stage IV NK cells.
15a/16-1FKO NK cells have altered IFN-g production due to a maturation defect
We next investigated whether miR-15a/16-1 deletion altered the function of NK cells. We found that total NK cell IFN-g responses to varying types of stimuli that induce a spectrum of NK cell production by NK cells (activating receptor ligation and cytokine receptor stimulation with IL-12 + IL-15, IL-12 + IL-18) were modestly but significantly diminished (Fig. 3A, 3B ) in 15a/16-1FKO mice. Because mature NK cells produce IFN-g, and this NK cell stage was diminished in 15a/16-1FKO mice, we next assessed the IFN-g responses on a permaturation-stage basis using low-intensity (anti-NK1.1) or middleintensity (IL-12 + IL-15) stimuli. Indeed, following IL-12 + IL-15 or anti-NK1.1 stimulation, the miR-15a/16-1FKO mice produced equivalent IFN-g protein compared with controls within each maturation stage. Thus, we reasoned that the decreased IFN-g production by total NK cell within 15a/16-1FKO mice was due to reduced numbers of stage IV NK cells (Fig. 3C, 3D ). IL-12 and IL-18 combined stimulation is a high-intensity stimulus for NK cell-IFN-g production, and 15a/16-1FKO NK cells produced comparable amounts of IFN-g to control NK cells with this maximal stimulation. We also examined NK cell degranulation (CD107a surface expression) in response to activating NK cell receptor ligation and cytotoxicity against YAC-1 tumor targets. In both assays, NK cell responses were similar for 15a/16-1FKO and control mice (data not shown), consistent with the variable correlations between NK cell terminal maturation and cytotoxicity against YAC-1 targets (5, 7). Thus, miR-15a/16-1FKO NK cells as a population exhibit a diminished IFN-g response due to an altered maturation profile, but intact degranulation and cytotoxicity.
miR-15/16 deficiency alters the expression of multiple mRNAs in NK cells
As miR-15/16 reduction led to both decreased maturation in vivo and increased proliferation, we sought to identify relevant gene targets of miR-15/16 for these processes in NK cells. Using TargetScan and Database for Annotation, Visualization and Integrated Discovery functional analyses, we found that miR-15/16 was predicted to target a number of genes in pathways involved in cell proliferation and differentiation (BP00224), including those expressed in NK cells (50) . To directly compare the global gene expression of 15a/16-1FKO and control NK cells, we performed mRNA microarrays on flow-sorted immature stage II/III (CD27 + ) NK cells to control for known differences in gene expression based on maturation stage. We identified a number of modest, yet significant, mRNA differences between the two genotypes. In order to enrich for genes directly regulated by miR-15/16, we filtered the microarray dataset for genes predicted to be targeted by miR-15/16 and found two genes that were upregulated with a high degree of significance and validated by real-time quantitative RT-PCR: Myb (Fig. 4A) and Lats2 (fold increase of 2 in 15/16-1FKO; p , 0.05). Lats2 has previously been shown to limit proliferation (51), which was inconsistent with the observed increased proliferation in 15a/16-1FKO NK cells. In contrast, Myb has been shown to promote cellular proliferation and is known to be important in hematopoietic development. We validated that RNA levels of Myb expression were higher in miR-15a/ 16-1FKO CD27 + NK cells by real-time quantitative RT-PCR (Fig. 4B ). Using immunoblot analysis of flow-sorted CD27 + NK cells, Myb protein levels were increased in 15a/16-1FKO NK cells (Fig. 4C) . We therefore focused on Myb as a potential mechanistic target for the NK cell-maturation defect present with miR-15/16 deficiency.
The transcription factor Myb is a direct target of miR-15/16
The two predicted miR-15/16 binding sites present in the murine Myb 39 UTR are highly conserved with humans (Fig. 5A ), and were energetically favorable targets for miRNA repression (Fig. 5B) . Consistent with several reports in human cell lines and primary cells (38, 52, 53) , we observed that the mouse Myb 39 UTR is a target of miR-15/16 family miRNAs using an in vitro luciferase reporter assay. When miR-15/16 overexpression plasmids were cotransfected with psiCheck2-luciferase sensor plasmid controlled by the murine Myb-39 UTR, we observed significant repression of the luciferase signal. Conversely, when miR-15/16 miRNAs were inhibited using cotransfection of an miR-15/16 sponge construct, the Myb-39 UTR luciferase signal was enhanced (Fig. 5C) . Finally, when the predicted seed sequences in the Myb-39 UTR are disrupted to prevent binding of miR-15/16 (Myb-Mutant), miR-15/16 is no longer able to suppress relative luciferase activity (Fig. 5D) Ncr1(NKp46),thepromoterdrivingCreinourmodel,isalsoexpressed in lymphoid tissue inducer NK-22 and related innate lymphoid cells, and we therefore confirmed the cell-intrinsic nature of the Ncr1-driven 15a/16-1FKO maturation defect by adoptive transfer (Fig. 6A-C) . Additionally, this adoptive-transfer system established an in vivo system for lentiviral manipulation and evaluation of primary murine NK cell maturation (Fig. 7A) 4 GFP + NK cells were injected i.v. into recipient mice and allowed to mature in vivo for 10 d. This time point was chosen based on a balance of detecting the adoptively transferred NK cells and the ability to observe consistent NK cell transitions from stage II to stages III and IV in vivo. The spleens from recipient mice were harvested, and the transferred GFP + NK cells were analyzed for maturation (Fig. 7B) . We found that 15a/ 16-1FKO NK cells had defective maturation after adoptive transfer (Fig. 7C ), confirming the cell-intrinsic nature of the defect and establishing the validity of this system for the ectopic expression/ repression experiments in primary NK cells.
miR-15/16 overexpression or Myb knockdown in adoptively transferred 15a/16-1FKO NK cells rescues NK cell maturation
In order to correct the aberrant overexpression of Myb in the miR-15a/16-1FKO NK cells, wegenerated twovectors: 1) a lentiviral short hairpin RNA (shRNA) directed against Myb (GFP-Myb shRNA), which was highly effective in repressing Myb protein expression; and 2) a lentiviral overexpression construct for miR-15/16, which effectively restores miR-15a/16 and was similarly effective at repressing Myb protein expression (Supplemental Fig. 4 ). Both lentiviruses include GFP to mark transduced cells for sorting and in vivo tracking. Ctrl and 15a/16-1FKO CD27 + CD11b 2 cells were transduced with viruses generated from these constructs, adoptively transferred, and then evaluated for maturation after 10 d (Fig. 7A) . As expected, miR-15/16 reinstatement restored miR-15a/16-1FKO NK cell maturation (Fig. 7D) . Additionally, Myb knockdown was able to restore the maturation of the miR-15a/16-1FKO NK cells to comparable levels as replacement of miR-15/16 (Fig. 7E) . Therefore, miR-15/16's direct targeting of Myb mRNA appears crucial to NK cell maturation, as 15a/16-1FKO NK cell maturation can be rescued by either restoration of miR-15/16 or forced downregulation of Myb.
Myb overexpression phenocopies the miR-15a/16-1FKO maturation defect
In order to specifically address the role of Myb in NK cell maturation, we cloned the Myb del10 mRNA isoform (MybD10), the major form of mouse Myb expressed in NK cells. The del10 isoform is also the dominant form of Myb expressed in B and T cells (50) and shares 90% homology with human Myb. We generated an overexpression construct for MybD10 (GFP-P2A-Myb) (Supplemental Fig. 4 ) and verified that Myb is overexpressed via immunoblot. We found that Ctrl stage II NK cells transduced to overexpress Myb had reduced maturation to stage IVafter 10 d in vivo (Fig. 7F) , similar to the 15a/ 16-1FKO mice (Fig. 7C) . Thus, forced Myb overexpression directly prevented NK cell maturation in vivo.
Myb overexpression drives an immature NK cell mRNA program
Differential expression of mRNAs in immatureversusmature murine NK cells have been identified by mRNA microarray analyses (6). We hypothesized that Myb overexpression in NK cells would result in enhanced mRNA expression of genes specific for immature NK cells and diminish expression of genes specific for mature NK cells. In order to test this hypothesis and directly assess the function of Myb as a transcription factor in NK cells, we transduced two independently generated NK cell lines (KY-1 and KY-2) (54) with either GFP or GFP-P2A-Myb expression vectors and performed a global analysis of mRNA expression. In this experiment, NK cell lines were used after multiple attempts at transducing primary immature NK cells failed to yield sufficient cell numbers to generate adequate RNA mass and quality for mRNA profiling following viral transduction. We identified 13 genes that were increased by at least 1.5-fold and 10 genes that were decreased by at least 1.5-fold consistently in both cell lines after Myb overexpression (Fig. 8A ). There was a high degree of correlation between genes induced by Myb overexpression and genes known to be preferentially expressed within the immature NK cells (6) . Correlation was also found between genes repressed by Myb overexpression and those preferentially expressed in mature NK cells (Fig. 8B) . Bioinformatic analysis of the regulatory regions of these genes revealed the presence of canonical Myb binding sites, suggesting a direct role for Myb in these mRNA alterations. We orthogonally validated gene expression changes that occur with Myb overexpression discovered via microarray (Fig. 8A) using real-time quantitative RT-PCR (Fig. 8C,  8D) . Collectively, these results support a model in which Myb induces and/or supports an immature NK cell program, and Myb downregulation results in mRNA expression changes that facilitate terminal NK cell maturation.
Discussion
The role of specific miRNAs in the regulation of NK cell development and maturation remains largely unknown (28) . This study revealed a critical role for miR-15/16, one of the most abundant miRNA families in NK cells, in the regulation of NK cell maturation. Using NK cell lineage-restricted miR-15/16 genetic deficiency models, we show that a 50% reduction of miR-15/16 expression resulted in decreased maturation of the CD27 2 CD11b + (stage IV) NK cell compartment. Further, we identified the transcriptional regulator Myb as one key mediator of this miR-15/16 NK cell maturation effect. Myb was confirmed as a direct target of miR-15/16 in vitro using both gain-and loss-of-function approaches. Myb mRNA and protein expression were reduced in vivo in immature miR-15/16-deficient NK cells, demonstrating the relevant regulation of this predicted target in the cellular context under study: primary NK cells. Further, Myb was directly linked to the maturation defect in miR-15/16-deficient NK cells using an in vivo primary NK cell maturation assay. These experiments identified that either restoration of miR-15/16 expression or Myb knockdown reversed the maturation block in miR-15/16-deficient NK cells. Moreover, forced Myb overexpression in WT NK cells also resulted in reduced NK cell maturation. These insights lead to new questions about the impact of Myb (and Myb's transcriptional targets) on normal NK cell maturation. Myb overexpression in NK cell lines resulted in enforcement of an immature NK cell mRNA profile, suggesting that Myb may be a key transcriptional regulator of the final steps of NK cell maturation. Thus, our study demonstrates that NK cell-intrinsic genetic alterations of a miRNA family can reveal new aspects of the NK cell molecular program.
The impact of miR-15/16 deficiency on NK cell maturation differs between tissues examined and appears modest in the BM and lung likely due to the maturation stages present. In the BM, CD27 When miR-15/16 is deficient, Myb mRNA and protein levels are increased, correlating with increased proliferation and disrupted stage III to IV maturation. The implication of these findings is that Myb must be downregulated in order for NK cells to complete maturation. Supporting these data, there is a large decrease in Myb mRNA and protein levels during this final phase of maturation. Further, 15a/16-1FKO NK cells that are able to mature to stage IV also have low levels of Myb. Collectively, these observations support a model in which lack of miR-15/16 boosts Myb levels in immature stage II/III NK cells, but NK cell maturation can still proceed, albeit at reduced efficiency, if a critical threshold of Myb is reached, at which time Myb gene expression is attenuated by mechanisms independent of miR-15/16. The identification of other factors that promote or inhibit the transcription and translation of Myb in NK cells, which has a number of regulatory mechanisms (35) , will further enhance our understanding of NK cell maturation. Interestingly, other factors known to be required for NK cell maturation are either stably expressed (Eomes, failure at stage II to III, and T-bet, failure at stage III to IV) or increased (Prdm1, failure at stage III to IV) throughout NK cell maturation. Because Prdm1 is a transcriptional repressor that increases during NK cell maturation (whereas Myb is reduced), it will be interesting to investigate whether Myb is downstream of Prdm1-regulated pathways. Additionally, Myb levels are increased in the absence of Ets1, indicating that Ets1 may promote the transcription of Myb, and this increased Myb expression may contribute to the maturation phenotype in the Ets1 2/2 mouse (22).
Myb has been previously shown to have a role in the differentiation of lymphocytes and other cells and is known to be targeted by miR-150 in NK cells (40) . This report analyzed haploinsufficient Myb +/2 mice, and identified increased numbers of mature NK cells, consistent with findings in miR-150-transgenic mice. It will be of interest to study conditional deletion of Myb in the NK cell lineage. We investigated the combined effect of miR-150 and miR-15/16 on Myb, given that the two miRNAs target distinct sites in the 39 UTR of Myb, but found no additive or synergistic effect using an in vitro luciferase assay. However, this does not exclude an in vivo cooperation of these two miRNAs at physiologic expression levels, and it will be interesting to investigate miR-150 and miR-15/16 cooperation in vivo. Interestingly, miR-150 deficiency was shown to decrease IFN-g production, similar to miR-15/16-deficient mice. For the miR-150-deficient mice, the reduced IFN-g was not apparently explained by the maturation change in those mice (40) , whereas miR-15/16-deficient mice had overall IFN-g production defects, with equivalent IFN-g production in all stages of NK cell maturation compared with controls. Both stage III and IV NK cells are major producers of IFN-g, and loss of stage IV NK cells in miR-15/16 deficiency resulted in modestly reduced INF-g production, without stage-specific differences when gating on stage II, III, or IV NK cells. We also observed no major differences between miR-15/16-deficient and control NK cells in cytotoxicity responses to YAC-1 tumor targets, not unexpected based on the inconsistent correlation of CD27/CD11b maturation subsets and NK cell cytotoxicity (5, 7). However, we acknowledge the possibility that miR-15/16 may also intrinsically modulate NK cell cytotoxicity. Further, altered miR-150 dosage led to additional effects on NK cells; for example, an altered Ly49A expression, an effect that was not observed in the miR-15a/16-1FKO. Moreover, whereas NK cells from miR-15a/16-1FKO exhibited enhanced proliferation, this effect was not reported in the global miR-150 2/2 model. These contrasting phenotypes suggest that although these highly expressed miRNAs have distinct pleiotropic sets of targets in NK cells, there may be targeting overlap for selected mRNAs, such as Myb.
Myb promotes the transcription of a number of genes associated with an immature NK cell phenotype while repressing genes associated with a mature NK cell phenotype. We identified a number of putative Mybtargeted genes in two mouse NK cell lines following forced overexpression of Myb. These Myb-promoted genes have a high degree of correlation to the expression of genes associated with immature NK cells, strongly suggesting that Myb promotes an immature NK cell phenotype. However, it will be important to validate these findings in primary NK cells using chromatin immunoprecipitation as robust Myb Abs for chromatin immunoprecipitation become available. Further, bioinformatic algorithms predict that canonical Myb target sites are present and overrepresented in genes affected by Myb overexpression. These data support that Myb promotes an immature NK cell phenotype. Our findings that Myb expression is also differentially regulated in human CD56 bright and CD56 dim subsets are consistent with the current model that CD56 bright are less mature than CD56 dim NK cells. The miR-15/16 binding sites in the Myb 39 UTR are highly conserved, resulting in parallel regulation of Myb by miR-15/16 in both species. Thus, our data in mice, and species conservation between miR-15/16 and Myb in mouse and humans, suggest that miR-15/16 control of Myb may regulate human NK cell differentiation. However, this is challenging to experimentally test, because there are differences in Myb family expression between mice and humans, with the additional Myb family member Mybl1 being significantly expressed in human, but not mouse, NK cells (50) . Our future studies will seek to test the hypothesis that miR-15/16 similarly targets Myb in human NK cells and thereby regulates human NK cell maturation. Additionally, we acknowledge that miR-15/16 family miRNAs have many targets in addition to Myb that may be contributing to the differentiation phenotype.
In summary, the regulation of Myb by miR-15/16 is essential for complete physiologic NK cell maturation invivo, revealing a previously unreported mechanism regulating NK cell development. In support of these findings, immature mouse NK cells transduced to overexpress Myb failed to mature in vivo, and 15a/16-1FKO NK cells failed to mature due to increased levels of Myb, which can be corrected either by reintroducing miR-15a/16 or small interfering RNA-mediated reduction of Myb. Myb promotes a number of transcripts directly associated with immature NK cells and represses those associated with mature NK cells. These data reveal a previously unreported miRNA-transcription factor regulatory pathway that controls NK cell maturation in vivo.
